Literature DB >> 17229862

Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil.

Eduardo Alexandrino Servolo Medeiros1, Timothy J Lott, Arnaldo Lopes Colombo, Patrício Godoy, Ana Paula Coutinho, Monica Santos Braga, Marcio Nucci, Mary E Brandt.   

Abstract

Fungal infections due to Candida species represent an important cause of nosocomial bloodstream infections. We report a large pseudo-outbreak of Candida guilliermondii fungemia that occurred in a university hospital in Brazil. C. guilliermondii was identified in 64 (43%) of the 149 blood samples drawn between June 2003 and July 2004. The samples were from patients in different wards of the hospital but concentrated in pediatric units. None of the patients had clinical signs of fungemia, and observational analysis revealed errors in the collection of blood samples. During the investigation of the pseudo-outbreak, C. guilliermondii was isolated from environmental surfaces and from the skin and nails of members of the nursing team. Through a subtyping analysis it was found that some of the nonpatient isolates were highly related to the patient isolates, and all the patient isolates were highly related. This is consistent with the hypothesis that the pseudo-outbreak was from a limited number of common sources. The adoption of intervention measures was effective in resolving the outbreak, supporting the hypothesis that the outbreak was due to poor techniques of drawing blood samples for culture.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229862      PMCID: PMC1829142          DOI: 10.1128/JCM.01878-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  A pseudo-outbreak of vancomycin-resistant Enterococcus faecium.

Authors:  Renato Satovschi Grinbaum; Thaís Guimarães; Elisa Kusano; Nair Hosino; Helio Sader; Rosangela Ferraz Cereda
Journal:  Infect Control Hosp Epidemiol       Date:  2003-06       Impact factor: 3.254

Review 2.  Controlling blood-culture contamination rates.

Authors:  Dennis J Ernst
Journal:  MLO Med Lab Obs       Date:  2004-03

3.  Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC).

Authors:  C Viscoli; C Girmenia; A Marinus; L Collette; P Martino; B Vandercam; C Doyen; B Lebeau; D Spence; V Krcmery; B De Pauw; F Meunier
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

4.  Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates.

Authors:  Timothy J Lott; Ruth E Fundyga; Mary E Brandt; Lee H Harrison; Andre N Sofair; Rana A Hajjeh; David W Warnock
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Through a glass darkly. Nosocomial pseudoepidemics and pseudobacteremias.

Authors:  D G Maki
Journal:  Arch Intern Med       Date:  1980-01

6.  DNA fingerprinting patterns of Candida species using HinfI endonuclease.

Authors:  S Fujita; T Hashimoto
Journal:  Int J Syst Evol Microbiol       Date:  2000-05       Impact factor: 2.747

7.  Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients.

Authors:  R B Schifman; C L Strand; F A Meier; P J Howanitz
Journal:  Arch Pathol Lab Med       Date:  1998-03       Impact factor: 5.534

8.  Nosocomial cluster of Candida guillermondii fungemia in surgical patients.

Authors:  L Masala; R Luzzati; L Maccacaro; L Antozzi; E Concia; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-18       Impact factor: 3.267

9.  Rapid identification of Candida species with species-specific DNA probes.

Authors:  C M Elie; T J Lott; E Reiss; C J Morrison
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

10.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

View more
  12 in total

1.  Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.

Authors:  Noura Al-Sweih; Suhail Ahmad; Leena Joseph; Seema Khan; Sandhya Vayalil; Rachel Chandy; Ziauddin Khan
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

2.  Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination.

Authors:  James E Kirby; Westyn Branch-Elliman; Mary T LaSalvia; Lorinda Longhi; Matthew MacKechnie; Grigoriy Urman; Linda M Baldini; Fatima R Muriel; Bernadette Sullivan; David S Yassa; Howard S Gold; Trevor K Wagner; Daniel J Diekema; Sharon B Wright
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

3.  Candida guilliermondii: biotechnological applications, perspectives for biological control, emerging clinical importance and recent advances in genetics.

Authors:  Nicolas Papon; Vincenzo Savini; Arnaud Lanoue; Andrew J Simkin; Joël Crèche; Nathalie Giglioli-Guivarc'h; Marc Clastre; Vincent Courdavault; Andriy A Sibirny
Journal:  Curr Genet       Date:  2013-04-25       Impact factor: 3.886

4.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

5.  Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948

6.  Three clustered cases of candidemia caused by Candida quercitrusa and mycological characteristics of this novel species.

Authors:  Meng Xiao; He Wang; Juan Lu; Sharon C-A Chen; Fanrong Kong; Xiao-Jun Ma; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2014-04-02       Impact factor: 5.948

7.  Genetic diversity of medically important and emerging Candida species causing invasive infection.

Authors:  Karina Bellinghausen Merseguel; Angela Satie Nishikaku; Anderson Messias Rodrigues; Ana Carolina Padovan; Renata Carmona e Ferreira; Analy Salles de Azevedo Melo; Marcelo Ribeiro da Silva Briones; Arnaldo Lopes Colombo
Journal:  BMC Infect Dis       Date:  2015-02-13       Impact factor: 3.090

8.  Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.

Authors:  Jing-Wei Cheng; Kang Liao; Timothy Kudinha; Shu-Ying Yu; Meng Xiao; He Wang; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

9.  Epidemiology of candidemia in Latin America: a laboratory-based survey.

Authors:  Marcio Nucci; Flavio Queiroz-Telles; Tito Alvarado-Matute; Iris Nora Tiraboschi; Jorge Cortes; Jeannete Zurita; Manuel Guzman-Blanco; Maria Elena Santolaya; Luis Thompson; Jose Sifuentes-Osornio; Juan I Echevarria; Arnaldo L Colombo
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  The identification and differentiation of the Candida parapsilosis complex species by polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer region of the rDNA.

Authors:  Leonardo Silva Barbedo; Maria Helena Galdino Figueiredo-Carvalho; Mauro de Medeiros Muniz; Rosely Maria Zancopé-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.